European Thyroid Journal (Jul 2024)

Epidemiology of thyroid-stimulating immunoglobulin in recent-onset symptomatic thyroid eye disease

  • Kenneth Ka Hei Lai,
  • Fatema Mohamed Ali Abdulla Aljufairi,
  • Jake Uy Sebastian,
  • Yingying Wei,
  • Ruofan Jia,
  • Karen Kar Wun Chan,
  • Elaine Yuen Ling Au,
  • Alan Chun Hong Lee,
  • Chiu Ming Ng,
  • Hunter Kwok Lai Yuen,
  • Wilson Wai Kuen Yip,
  • Alvin Lerrmann Young,
  • George Pak Man Cheng,
  • Clement Chee Yung Tham,
  • Chi Pui Pang,
  • Kelvin Kam Lung Chong

DOI
https://doi.org/10.1530/ETJ-23-0129
Journal volume & issue
Vol. 13, no. 4
pp. 1 – 7

Abstract

Read online

Purpose: This study aims to report correlations between thyroid-stimulating immunoglobulin (TSI) and both clinical and radiological parameters in recent-onset symptomatic thyroid eye disease (TED) patients. Methods: A prospective cohort study of TED patients managed at the Chinese University of Hong Kong from January 2014 to May 2022. Serum TSI levels were determined with the functional assay. Outcomes included the Clinical Activity Score (CAS), marginal reflex distance1 (MRD1), extraocular muscle motility restriction (EOMy), exophthalmos, and diplopia. The radiological assessment included cross-sectional areas and signal of extraocular muscles on STIR-sequence MRI. Results: A total of 255 (197 female) treatment-naive patients, with an average onset age of 50 ± 14 years (mean ± s.d.), were included. Elevated pre-treatment TSI level was observed in 223 (88%) patients. There was a weak positive correlation between TSI and CAS (r = 0.28, P = 0.000031), MRD1 (r = 0.17, P = 0.0080), and the size of the levator palpebrae superioris/superior rectus complex (r = 0.25, P = 0.018). No significant correlation existed between TSI and STIR signals. The AUC and optimal cut-off value for clinical active TED were 0.67 (95% CI: 0.60–0.75) and 284% (specificity: 50%, sensitivity: 85%). In total, 64 patients received intravenous methylprednisolone (IVMP) during the study interval, and they had a higher baseline TSI level than those who did not have IVMP (P = 0.000044). Serial post-IVMP TSI among the 62 patients showed a significant reduction compared to the baseline level (P < 0.001). Both the baseline and post-IVMP TSI levels, and percentages of TSI changes were comparable between patients who responded and did not respond to the first course of IVMP. Conclusion: TSI can be a serum biomarker for the diagnosis, prognosis, and treatment response of TED. Further validation should be warranted.

Keywords